32 genetic variations could play a role in osteoporosis risk

A team of international researchers have found 32 new genetic regions linked to fractures and osteoporosis. According to the new study published in the April 15 online edition of Nature Genetics, changes in these regions could offer protection from, or greater risk for, bone-weakening disease.

“We're learning that the genetic architecture of disease is very complex,” one of the study's authors and the methodological leader of the consortium, Dr. John Ioannidis, chief of the Stanford Prevention Research Center, said in a university news release.

The research, which involved 17 studies that compared common genetic variants in more than 100,000 people, pinpointed six regions linked to risk of fractures of the femur (thigh bone) or lower back.

Authors warn however that it would still be difficult to predict who is at greater risk for bone disease. People with the highest number of variants associated with decreased bone mineral density were only about one and a half times more likely than people with an average number of variants to have osteoporosis. The risk for fractures was only slightly higher. Meanwhile, compared to those with the fewest variants, people with the most variants were still just three to four times more likely to have had fractures and lower bone mineral density, the study revealed.

“As a result, the next step of incorporating this information into basic patient care is not clear,” Ioannidis concluded. “Each variant conveys a small quantum of risk or benefit. We can't predict exactly who will or won't get a fracture,” he explained.

The authors noted, their research could lead to the development of new anti-osteoporosis drugs. But even larger studies are needed to identify all of the genes critical to fighting bone disease, they added.

“We saw many of these regions and genes clustering within specific types of pathways, which suggests certain disease mechanisms. It certainly wouldn't be unexpected to eventually identify many more genetic regions involved in the regulation of osteoporosis and fracture risk,” Ioannidis said. “In reality, there may be 500 or more gene variants regulating osteoporosis. To find all of them, we'll need to study millions of patients. Is this unrealistic? I don't think so. Sooner or later this will be feasible,” he added.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). 32 genetic variations could play a role in osteoporosis risk. News-Medical. Retrieved on December 02, 2020 from https://www.news-medical.net/news/20120416/32-genetic-variations-could-play-a-role-in-osteoporosis-risk.aspx.

  • MLA

    Mandal, Ananya. "32 genetic variations could play a role in osteoporosis risk". News-Medical. 02 December 2020. <https://www.news-medical.net/news/20120416/32-genetic-variations-could-play-a-role-in-osteoporosis-risk.aspx>.

  • Chicago

    Mandal, Ananya. "32 genetic variations could play a role in osteoporosis risk". News-Medical. https://www.news-medical.net/news/20120416/32-genetic-variations-could-play-a-role-in-osteoporosis-risk.aspx. (accessed December 02, 2020).

  • Harvard

    Mandal, Ananya. 2018. 32 genetic variations could play a role in osteoporosis risk. News-Medical, viewed 02 December 2020, https://www.news-medical.net/news/20120416/32-genetic-variations-could-play-a-role-in-osteoporosis-risk.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Researchers discover potential cellular target for eliminating bone breakdown in osteoporosis